- (a) When furnishing an infused compounded antineoplastic HD for administration, the facility shall attach and prime tubing and attach a CSTD when appropriate.
- (b) When dispensing a compounded antineoplastic HD to a patient or patient's agent, the pharmacy shall provide, or offer for purchase, a sufficient supply of ASTM D-6978 standard chemotherapy gloves to allow for appropriate handling and disposal of the HD. A compounded antineoplastic HD preparation that is administered to an inpatient of a health care facility licensed pursuant to section 1250 of the Health and Safety Code is exempt from this requirement.
In addition to the standards in USP Chapter 800, the following requirements apply to a facility where compounding of HDs is performed.
Note: Authority cited: Sections 4005, 4126.8 and 4127, Business and Professions Code. Reference: Sections 4005 and 4126.8, Business and Professions Code.
History
1. New section filed 6-19-2025; operative 10-1-2025 (Register 2025, No. 25).